Education
About Us
Working with TipRanks
Follow Us
Bal Pharma Limited (IN:BALPHARMA)
:BALPHARMA
BALPHARMA Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹76.30 - ₹157.90
Previous CloseN/A
Volume11.87K
Average Volume (3M)2.97K
Market Cap
₹1.58B
Enterprise Value₹2.83B
Total Cash (Recent Filing)₹261.56M
Total Debt (Recent Filing)₹1.55B
Price to Earnings (P/E)21.7
Beta0.66
Next Earnings
Aug 07, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 17, 2024Dividend Yield1.21%
Share Statistics
EPS (TTM)3.40
Shares Outstanding15,920,872
10 Day Avg. Volume2,539
30 Day Avg. Volume2,971
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)1.51
Price to Sales (P/S)0.00
P/FCF Ratio-120.29
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BALPHARMA FAQ
What was Bal Pharma Limited’s price range in the past 12 months?
Bal Pharma Limited lowest stock price was ₹76.30 and its highest was ₹157.90 in the past 12 months.
What is Bal Pharma Limited’s market cap?
Bal Pharma Limited’s market cap is ₹1.58B.
When is Bal Pharma Limited’s upcoming earnings report date?
Bal Pharma Limited’s upcoming earnings report date is Aug 07, 2025 which is in 45 days.
How were Bal Pharma Limited’s earnings last quarter?
Bal Pharma Limited released its earnings results on May 29, 2025. The company reported ₹3.4 earnings per share for the quarter, beating the consensus estimate of N/A by ₹3.4.
Is Bal Pharma Limited overvalued?
According to Wall Street analysts Bal Pharma Limited’s price is currently Overvalued.
Does Bal Pharma Limited pay dividends?
Bal Pharma Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 1.21%. See more information on Bal Pharma Limited dividends here
What is Bal Pharma Limited’s EPS estimate?
Bal Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bal Pharma Limited have?
Bal Pharma Limited has 15,920,872 shares outstanding.
What happened to Bal Pharma Limited’s price movement after its last earnings report?
Bal Pharma Limited reported an EPS of ₹3.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.812%.
Which hedge fund is a major shareholder of Bal Pharma Limited?
Currently, no hedge funds are holding shares in IN:BALPHARMA
Technical Analysis
Alkem Laboratories Ltd.
―
Cipla Ltd
―
Lupin Limited
―
Sun Pharmaceutical Industries Limited
―
Torrent Pharmaceuticals Ltd
―